Literature DB >> 30963571

Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection.

Yuntong Li1, Bingfen Ma2, Zhenyu Yin1, Pingguo Liu1, Jianming Liu1, Jie Li1, Fuqiang Wang1, Huimin Chen1.   

Abstract

The prognosis of hepatocellular carcinoma (HCC) after R0 resection is unsatisfactory due to the high rate of recurrence. In this study, we investigated the recurrence-related RNAs and the underlying mechanism. The long noncoding RNA (lncRNA), microRNA (miRNA), and messenger RNA (mRNA) expression data and clinical information of 247 patients who underwent R0 resection patients with HCC were obtained from The Cancer Genome Atlas. Comparing the 1-year recurrence group (n = 56) with the nonrecurrence group (n = 60), we detected 34 differentially expressed lncRNAs (DElncRNAs), five DEmiRNAs, and 216 DEmRNAs. Of these, three DElncRNAs, hsa-mir-150-5p, and 11 DEmRNAs were selected for constructing the competing endogenous RNA (ceRNA) network. Next, two nomogram models were constructed based separately on the lncRNAs and mRNAs that were further selected by Cox and least absolute shrinkage and selection operator regression analysis. The two nomogram models that showed a high prediction accuracy for disease-free survival with the concordance indexes at 0.725 and 0.639. Further functional enrichment analysis of DEmRNAs showed that the mRNAs in the ceRNA network and nomogram models were associated with immune pathways. Hence, we constructed a hsa-mir-150-5p-centric ceRNA network and two effective nomogram prognostic models, and the related RNAs may be useful as potential biomarkers for predicting recurrence in patients with HCC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  The Cancer Genome Atlas; competing endogenous RNA; early recurrence; hepatocellular carcinoma; nomogram

Mesh:

Substances:

Year:  2019        PMID: 30963571     DOI: 10.1002/jcp.28634

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.

Authors:  Ping Yan; Zuotian Huang; Tong Mou; Yunhai Luo; Yanyao Liu; Baoyong Zhou; Zhenrui Cao; Zhongjun Wu
Journal:  BMC Cancer       Date:  2021-04-20       Impact factor: 4.430

2.  lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma.

Authors:  Siyao Wu; Yayan Deng; Yue Luo; Jiaxiang Ye; Zhihui Liu
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

3.  Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network.

Authors:  Zhangya Pu; Yuanyuan Zhu; Xiaofang Wang; Yun Zhong; Fang Peng; Yiya Zhang
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

4.  An integrated analysis of the competing endogenous RNA network and co-expression network revealed seven hub long non-coding RNAs in osteoarthritis.

Authors:  Haitao Chen; Liaobin Chen
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

5.  Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.

Authors:  Wei Xu; Ruineng Li; Fei Liu
Journal:  Cancer Manag Res       Date:  2020-03-09       Impact factor: 3.989

6.  Mapping Intellectual Structure for the Long Non-Coding RNA in Hepatocellular Carcinoma Development Research.

Authors:  Zhifeng Lin; Xiaohui Ji; Nana Tian; Yu Gan; Li Ke
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

7.  Comprehensive analysis of competitive endogenous RNA network in colorectal cancer.

Authors:  Meng-Yi Zhang; Bin-Han Guo
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.